Delivery Order SPE2DB24D1034-SPE2DB24FVXZ5
Award Date 2/14/24
Potential Completion Date 2/15/24
Potential Value $12K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $6,782.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, with an ultimate completion date of November 20, 2023. The contract is a Delivery Order under a Firm Fixed Price pricing arrangement, with no set-aside designation indicated. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $7,964.76, is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccines to support military healthcare programs. This is a Firm Fixed Price Delivery Order with a completion date of January 19, 2024. The contract was awarded on January 18, 2024 and was not set aside for any specific...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,847.96, is for the delivery of 4554627453 - TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract has an ultimate completion date of September 2, 2021 and uses a Firm Fixed Price pricing type. This award is a Delivery Order and was not set aside for any specific business type. Amerisourcebergen Drug Corp, as a major...
- This federal contract award, valued at $7,537.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company and subsidiary of Cencora, Inc. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, which is a vaccine product. The contract has an ultimate completion date of October 24, 2023 and is a firm fixed-price delivery order. The contract award is not associated with a set-aside designation, indicating it was...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $58,480.00 firm fixed-price delivery order is for the supply of 4563469535 - TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine, with a completion date of January 30, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $14,123.26, is for the delivery of 4,563,803,567 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. This is a delivery order contract with a firm fixed price, and the ultimate completion date is February 29, 2024. The contract was awarded on February 28, 2024, and there was no set-aside designation....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,034.55 firm-fixed-price delivery order is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The award has an ultimate completion date of January 9, 2024 and was made without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, to the Defense Logistics Agency (DLA). The $11,196.00 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on October 22, 2021, with a completion date of October 25, 2021. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This is a federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,745.24, is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. This is a delivery order contract with a firm fixed price pricing type, with a completion date of May 6, 2024. The contract was awarded on May 3, 2024 and does not have a set-aside designation, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract has a ceiling value of $11,534.00 and an ultimate completion date of January 12, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which serves as the parent company. This...